These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29785244)

  • 1. More than Just an Immunosuppressant: The Emerging Role of FTY720 as a Novel Inducer of ROS and Apoptosis.
    Takasaki T; Hagihara K; Satoh R; Sugiura R
    Oxid Med Cell Longev; 2018; 2018():4397159. PubMed ID: 29785244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells.
    Zhang L; Wang H; Ding K; Xu J
    Toxicol Lett; 2015 Jul; 236(1):43-59. PubMed ID: 25939952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTY720 stimulated ROS generation and the Sty1/Atf1 signaling pathway in the fission yeast Schizosaccharomyces pombe.
    Hagihara K; Mizukura A; Kitai Y; Yao M; Ishida K; Kita A; Kunoh T; Masuko T; Matzno S; Chiba K; Sugiura R
    Genes Cells; 2014 Apr; 19(4):325-37. PubMed ID: 24506481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis.
    Chiba K; Adachi K
    Future Med Chem; 2012 Apr; 4(6):771-81. PubMed ID: 22530640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FTY720 (Fingolimod) attenuates basal and sphingosine-1-phosphate-evoked thyroid cancer cell invasion.
    Kalhori V; Magnusson M; Asghar MY; Pulli I; Törnquist K
    Endocr Relat Cancer; 2016 May; 23(5):457-68. PubMed ID: 26935838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanisms of ROS in U266 cell death induced by FTY720].
    Li YC; Liu ZG; Yao K; Wang HH; Hu R; Yang W; Liao AJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):643-6. PubMed ID: 23815914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (fingolimod) in multiple sclerosis.
    Lee CW; Choi JW; Chun J
    Arch Pharm Res; 2010 Oct; 33(10):1567-74. PubMed ID: 21052934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fingolimod protects cultured cortical neurons against excitotoxic death.
    Di Menna L; Molinaro G; Di Nuzzo L; Riozzi B; Zappulla C; Pozzilli C; Turrini R; Caraci F; Copani A; Battaglia G; Nicoletti F; Bruno V
    Pharmacol Res; 2013 Jan; 67(1):1-9. PubMed ID: 23073075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fingolimod impedes Schwann cell-mediated myelination: implications for the treatment of immune neuropathies?
    Köhne A; Stettner M; Jangouk P; Dehmel T; Hartung HP; Lehmann HC; Kieseier BC
    Arch Neurol; 2012 Oct; 69(10):1280-9. PubMed ID: 22751954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTY720 for cancer therapy (Review).
    Zhang L; Wang HD; Ji XJ; Cong ZX; Zhu JH; Zhou Y
    Oncol Rep; 2013 Dec; 30(6):2571-8. PubMed ID: 24100923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes.
    Ottenlinger F; Schwiebs A; Pfarr K; Wagner A; Grüner S; Mayer CA; Pfeilschifter JM; Radeke HH
    Eur J Immunol; 2016 Apr; 46(4):941-51. PubMed ID: 26683421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo.
    Hu Y; Lee X; Ji B; Guckian K; Apicco D; Pepinsky RB; Miller RH; Mi S
    Mol Cell Neurosci; 2011 Sep; 48(1):72-81. PubMed ID: 21740973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTY720 induces apoptosis in B16F10-NEX2 murine melanoma cells, limits metastatic development in vivo, and modulates the immune system.
    Pereira FV; Arruda DC; Figueiredo CR; Massaoka MH; Matsuo AL; Bueno V; Rodrigues EG
    Clinics (Sao Paulo); 2013 Jul; 68(7):1018-27. PubMed ID: 23917669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling.
    Hung JH; Lu YS; Wang YC; Ma YH; Wang DS; Kulp SK; Muthusamy N; Byrd JC; Cheng AL; Chen CS
    Cancer Res; 2008 Feb; 68(4):1204-12. PubMed ID: 18281497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft.
    Ubai T; Azuma H; Kotake Y; Inamoto T; Takahara K; Ito Y; Kiyama S; Sakamoto T; Horie S; Muto S; Takahara S; Otsuki Y; Katsuoka Y
    Anticancer Res; 2007; 27(1A):75-88. PubMed ID: 17352219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine-1-phosphate and FTY720 as anti-atherosclerotic lipid compounds.
    Tölle M; Levkau B; Kleuser B; van der Giet M
    Eur J Clin Invest; 2007 Mar; 37(3):171-9. PubMed ID: 17359484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive effects of FTY720 during trauma-induced neuropathic pain are mediated by spinal S1P receptors.
    Zhang DD; Linke B; Suo J; Zivkovic A; Schreiber Y; Ferreirós N; Henke M; Geisslinger G; Stark H; Scholich K
    Biol Chem; 2015 Jun; 396(6-7):783-94. PubMed ID: 25720064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720.
    Kihara A; Igarashi Y
    Biochim Biophys Acta; 2008 Sep; 1781(9):496-502. PubMed ID: 18555808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
    Chiba K
    Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Effects of FTY720 and its Derivatives.
    Han M; Liu X; Hailati S; Maihemuti N; Nurahmat N; Dilimulati D; Baishan A; Aikebaier A; Zhou W; Pan Y
    Curr Top Med Chem; 2024; 24(3):192-200. PubMed ID: 38185890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.